In support of this hypothesis, OPA1 overexpression blunts damage of highly metabolically active organs in response to apoptotic, necrotic, and atrophic stimuli [42], as well as ameliorates motor performance in a model of myopathy caused by muscle-specific deletion of the mitochondrial subunit cytochrome c oxidase 15 [43]. The gene discussed is OPA1; the disease is myopathy.